IFF reorganization
This article was originally published in The Rose Sheet
Executive Summary
International Flavors & Fragrances will record a nonrecurring pre-tax charge of approximately $20 mil. ($13 mil. after tax) in the first quarter as a result of employee terminations, company reports April 3. IFF recently eliminated over 150 positions primarily in North America and Europe as part of reorganization effort expected to be completed later this year. IFF revealed its reorganization plan aimed at saving approximately $25 mil.-$30 mil. annually in 2000 (1"The Rose Sheet" Oct. 9, 2000, p. 5). At the time of the announcement, IFF expected to incur $90 mil.-$100 mil. in related costs, but the fragrance supplier now anticipates charges of approximately $110 mil. Company expects to report first quarter sales up 5%-6% in line with earlier guidance...
You may also be interested in...
IFF Reorganization Plan To Save $25 Mil.-$30 Mil. By 2003, CEO Predicts
International Flavors & Fragrances will generate annual savings of $25 mil.-$30 mil. by 2003 under a reorganization plan detailed by CEO Richard Goldstein during an analyst conference call Oct. 5.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.